Open AccessAlbumin infusion may decrease the incidence and severity of overt hepatic encephalopathy in liver cirrhosis
Author(s) -
Zhaohui Bai,
Mauro Bernardi,
Eric M. Yoshida,
Hongyu Li,
Xiaozhong Guo,
Nahúm MéndezSánchez,
Yingying Li,
Ran Wang,
Jiao Deng,
Xingshun Qi
Publication year - 2019
Publication title -
aging
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.473
H-Index - 90
ISSN - 1945-4589
DOI - 10.18632/aging.102335
Subject(s) - medicine , cirrhosis , albumin , hepatic encephalopathy , incidence (geometry) , retrospective cohort study , odds ratio , gastroenterology , serum albumin , encephalopathy , physics , optics
The role of human albumin infusion for the prevention and treatment of overt hepatic encephalopathy (HE) in liver cirrhosis remains unclear.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom